Switzerland· 70182001
Hibiwash 40 mg/ml, Lösung zur Anwendung auf der Haut
A chlorhexidine product containing chlorhexidini digluconas, registered in Switzerland by MÖLNLYCKE HEALTH CARE AG and dispensed under Swissmedic category D. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Chlorhexidine is registered in 11 of 19 countries.
Countries holding a registration under ATC D08AC02 (chlorhexidine), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Chlorhexidine · ATC D08AC02
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- chlorhexidini digluconas
- Manufacturer
- MÖLNLYCKE HEALTH CARE AG
- Country
- Switzerland (CH)
- ATC code
- D08AC02
- ATC class
- Chlorhexidine
- Swissmedic category
- D
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhexidine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAntiseptic Skin CleanserRite Aid
- SpainHIBISCRUB 40 mg/ml SOLUCION CUTANEAMoelnlycke Health Care Ab
- BelgiumHibiscrub 40 mg/mlMölnlycke Health Care AB SE
- NetherlandsHibiscrub, oplossing voor cutaan gebruik 40 mg/mlMolnlycke Health Care AB
- SwedenHibiscrub 40 mg/ml Kutan lösningMölnlycke Health Care AB
- FranceCHLORHEXIDINE DIGLUCONATE HIBI 40 mg/mL, solution pour application cutanéeMÖLNLYCKE HEALTH CARE (SUEDE)
- IcelandHibiwashMölnlycke Health Care AB
- FinlandHibiwash
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Chlorhexamed, Chlorhexamed Fluid
- Belgium · Cedium, Cedium Chlorhexidini Alcoholicus
- Bulgaria · Septofort
- Czechia · Corsodyl, Septofort
- Germany · Chlorhexamed Fluid, Chlorhexamed Forte Alkoholfrei
- Denmark · Cristalmina
- Spain · Aquaseptic Pharma, Aquaseptic Pharma Orange
- Finland · Corsodyl, Cristalmina
- France · Chlorhexidine Aqueuse Sterile Gilbert, Chlorhexidine Arrow
- United Kingdom (Northern Ireland) · ‘hibitane’ Antiseptic, Acnemed Skin Wash
- Greece · Chlorel, Septizer Pro
- Hungary · Septofort
- Ireland · Chlorhexidine Acetate Bp Baxter Holding, Corsodyl
- Iceland · Corsodyl, Lacudex
- Italy · Broxo Din, Clorexifarm
- Luxembourg · Cedium, Cedium Chlorhexidini 0,05
- Malta · Chlorhexidine Acetate Bp Baxter Holding, Furaseptic
- Netherlands · Corsodyl, Hibiscrub
- Norway · Corsodyl, Cristalmina
- Poland · Corsodyl, Hydrex S
- Portugal · Alospray, Corsodyl Dental
- Romania · Corsodyl Mint Mouthwash
- Sweden · Bepandex, Corsodyl
- Slovakia · Corsodyl, Septofort
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/84aa9573-e233-41d5-b5b5-cbe9f2b14ed8 GET /v1/drugs/84aa9573-e233-41d5-b5b5-cbe9f2b14ed8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about chlorhexidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.